Comms agency WCG expands team
July 24, 2012Medical Communications London, WCG, healthcare comms
WCG has announced a string of appointments whilst also being ranked twelfth among healthcare firms in PRWeek’s UK league tables. …
Speedy approval for Onyx’ multiple myeloma drug
July 24, 2012Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade
Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma. Kyprolis (carfilzomib), a …
Pfizer and Janssen’s Alzheimer’s drug fails
July 24, 2012Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab
Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …
NICE to assess high cost drugs for rare conditions
July 24, 2012Sales and Marketing AGNSS, NHS, NICE, Rawlins, rare conditions
NICE is to be responsible next year for assessing high cost drugs for people with rare medical conditions as part …
Microneedles could transform delivery of drugs to the eye
July 24, 2012Manufacturing and Production, Research and Development AMD, avastin, microneedles
Researchers in the US have demonstrated for the first time that drugs can be successfully delivered to the eye using …
ABPI names new Medical, Innovation and Research director
July 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bina Rawal, Stephen Whitehead
The ABPI has named its new Medical, Innovation and Research director as Dr Bina Rawal, who will join the trade …
EMA recommends first new gene therapy
July 24, 2012Business Services, Research and Development, Sales and Marketing CHMP, EMA, Glybera, uniQure
Glybera is now on the cusp of becoming the first gene therapy treatment to be approved in the West. The …
Pharma buoys Albemarle results in second quarter
July 24, 2012Manufacturing and Production Albemarle, manufacturing
Albemarle succumbed to pressure in the market in the second quarter as sales fell 8% to $685 million, although the …
Supplier defect blamed in Hospira recall case
July 24, 2012Manufacturing and Production FDA, Hospira, Michael Ball
Hospira has concluded that a supplier defect was the root cause of its recall of four cancer drugs in the …
Contract research news in brief
July 23, 2012Research and Development Clinipace Worldwide, Medpace, Paraxel, Synexus, eResearch Technologies and invivodata
A round-up of recent developments in the contract research sector, including updates from Parexel, Medpace, Clinipace, Synexus and ERT.
BBSRC appoints new director of science
July 23, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BBSRC, Melanie Welham
BBSRC the government-funded bioscience research organisation has announced the appointment of Professor Melanie Welham as director of science. Welham is …
CCGs already improving patient care
July 23, 2012Sales and Marketing CCGs, Commissioning Board, GPs, NHS, NHSCC, reforms
Clinical Commissioning Groups – the new structures set up under the Health and Social Care Act to control most of …
Onyx appoints John Osborn as senior VP
July 20, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing John Osborn, Onyx
Onyx Pharmaceuticals has announced the appointment of John Osborn as senior vice president, Global Corporate Affairs. In his role, Osborn …
Waggener Edstrom appoints vice president
July 20, 2012Business Services, Medical Communications, Sales and Marketing Anna Gray, Waggener Edstrom
Comms agency Waggener Edstrom has announced that Anna Gray has been appointed to lead the agency’s UK Healthcare Practice. Joining …
Grünenthal and Vifor breach Code
July 20, 2012Sales and Marketing ABPI, Grunenthal, PMCPA, Vifor, code, tapentadol
Grünenthal and Vifor Pharma UK have been named and shamed for serious infringements of the ABPI Code of Practice. Adverts …
Humira powers ahead as Abbott prepares split
July 19, 2012Sales and Marketing AbbVie, Abbott, Humira, RA
Humira maintained its rapid growth in the second quarter, helping keep Abbott buoyant ahead of its split into two separate …
Home Digital appoints Doctors.net.uk senior head
July 19, 2012Business Services, Medical Communications, Sales and Marketing Doctors.net.uk, Home Digital
Digital marketing agency Home Digital has hired Marie Little as the company’s commercial director. In this newly created role she …
Senior appointments for Takeda’s Europe and Canada team
July 18, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda
Takeda Pharmaceuticals has appointed David Milton as head of Marketing & Product Portfolio Strategy, and Dr Nizamul Islam as head …
New J&J chief still struggling with scandals
July 18, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Risperdal, Weldon, Xarelto, Zytiga
Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …
GSK raises stake in Amicus for Fabry drug
July 18, 2012Research and Development, Sales and Marketing Amicus, Fabry, GSK, R&D
GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
